New Diabetes Medications Raise New Perioperative Concerns for the Anesthesiologist
Anesthesiologists increasingly care for patients with diabetes perioperatively. The importance of optimal glucose management to reduce the incidence of complications in patients with diabetes is well established. Perioperative management to maintain relatively normal blood glucose levels is complex, given the broad variety of medications used to treat relative or absolute insulin deficiency. In this issue, Peacock et al1 introduce the anesthesiologist to a newer class of antidiabetes medications, the sodium glucose cotransporter 2 inhibitors (SGLT2i), and review the unique considerations for patients taking these agents perioperatively.